Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | SLC5A1 | P13866 | 1/20 | 0.31 |
| ▸ | SLC5A2 | P31639 | 1/20 | 0.31 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.31 |
| ▸ | PLA2G5 | P39877 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | FASN | P49327 | 1/20 | 0.30 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5996573 | 0.82 | FASN (0.37) | MEN1KMT2ASLC5A1SLC5A2PLA2G2A | |
| SCHEMBL5994212 | 0.82 | F2R (0.38) | MEN1KMT2ASMN1; SMN2ALDH1A1MAPT | |
| SCHEMBL5993510 | 0.78 | FASN (0.35) | SLC5A1SLC5A2PLA2G2APLA2G5SMN1; SMN2 | |
| SCHEMBL5997322 | 0.78 | CYP3A4 (0.35) | MEN1KMT2A | |
| SCHEMBL5996181 | 0.76 | PLA2G2A (0.35) | PLA2G2APLA2G5FASN | |
| SCHEMBL5725252 | 0.75 | GSK3B (0.47) | MEN1KMT2ASMN1; SMN2MCL1ALDH1A1 | |
| SCHEMBL5997944 | 0.74 | TYK2 (0.44) | MEN1KMT2AALDH1A1 | |
| SCHEMBL5997559 | 0.74 | ALDH1A1 (0.41) | MEN1KMT2AMCL1ALDH1A1MAPT | |
| SCHEMBL5997078 | 0.73 | ALDH1A1 (0.44) | MEN1KMT2ASMN1; SMN2ALDH1A1MAPT | |
| SCHEMBL5996031 | 0.71 | FOLH1 (0.41) | KMT2ASMN1; SMN2MCL1ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7109250-B2 | Multimer forms of acylphosphines and their derivatives | CIBA SPECIALTY CHEMICALS CORP. (US) | 2006-09-19 | — | — | US | disclosed |
| US-7026017-B2 | Photoinitiators for acrylic esters; reacting an acyl halide with a metal benzoyl phosphine; cable coatings, screen printing stencils, resist materials, colour filters, electrical encapsulation | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2006-04-11 | — | — | US | disclosed |
| US-6969733-B2 | Photoinitiators | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2005-11-29 | — | — | US | disclosed |
| US-20050004247-A1 | Multimer forms of acylphosphines and their derivatives | CIBA SPECIALTY CHEMICALS CORP. | 2005-01-06 | — | — | US | disclosed |
| EP-1446410-A1 | MULTIMER FORMS OF ACYLPHOSPHINES AND THEIR DERIVATIVES | Ciba SC Holding AG (CH) | 2004-08-18 | — | — | EP | disclosed |
| US-6737549-B2 | PHOTOINITIATORS FOR ACRYLATE COATINGS | CIBA SPECIALTY CHEMICALS CORPORATION | 2004-05-18 | — | — | US | disclosed |
| US-20030139485-A1 | Photoinitiators | WOLF JEAN-PIERRE (CH) | 2003-07-24 | — | — | US | disclosed |
| US-20030130370-A1 | Photoinitiators for acrylic esters; reacting an acyl halide with a metal benzoyl phosphine; cable coatings, screen printing stencils, resist materials, colour filters, electrical encapsulation | WOLF JEAN-PIERRE (CH) | 2003-07-10 | — | — | US | disclosed |
| WO-2003044030-A1 | MULTIMER FORMS OF ACYLPHOSPHINES AND THEIR DERIVATIVES | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2003-05-30 | — | — | WO | disclosed |
| US-20020026049-A1 | Photoinitiators for acrylate coatings | CIBA SPECIALTY CHEMICALS CORP. | 2002-02-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030139485-A1 | Photoinitiators | DHCR24, NR1I3, CBR1 | MEN1 3862/4885KMT2A 1784/4885SLC5A1 2564/4885 |
| US-20030130370-A1 | Photoinitiators for acrylic esters; reacting an acyl halide with a metal benzoyl phosphine; cable coatings, screen printing stencils, resist materials, colour filters, electrical encapsulation | SMARCC1, ARPC5L, DHCR24 | MEN1 2456/4885KMT2A 761/4885SLC5A1 1133/4885 |
| US-20020026049-A1 | Photoinitiators for acrylate coatings | DHCR24, NR5A1, NR2C2 | MEN1 3695/4885KMT2A 1577/4885SLC5A1 1583/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.